Compare BYAH & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYAH | BFRI |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 9.7M |
| IPO Year | 2024 | 2021 |
| Metric | BYAH | BFRI |
|---|---|---|
| Price | $0.21 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | ★ 230.5K | 103.6K |
| Earning Date | 08-26-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,768,120.00 | ★ $37,164,000.00 |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | N/A | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.65 | 5.11 |
| 52 Week Low | $0.20 | $0.54 |
| 52 Week High | $41.49 | $1.87 |
| Indicator | BYAH | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 39.78 |
| Support Level | N/A | $0.77 |
| Resistance Level | N/A | $0.83 |
| Average True Range (ATR) | 0.00 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 29.89 |
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.